Table 1.
Participant Characteristics
| Enrolled (n=75) | ||
|---|---|---|
| n | % | |
| Referral source | ||
| Urgent care | 19 | 25% |
| Primary care team | 22 | 29% |
| PHAST team | 12 | 16% |
| LINCS | 2 | 3% |
| Surveillance data | 19 | 25% |
| Other | 4 | 5% |
| Age | ||
| 18–35 | 21 | 28% |
| 35–50 | 29 | 39% |
| >50 | 25 | 33% |
| Gender | ||
| Cisgender man | 64 | 85% |
| Cisgender woman | 7 | 9% |
| Transgender woman | 1 | 1% |
| Nonbinary/Gender nonconforming | 3 | 4% |
| Race/Ethnicity | ||
| Black/African American | 26 | 35% |
| White | 34 | 45% |
| Hispanic/Latinx | 7 | 9% |
| Asian/Pacific Islander | 0 | 0% |
| American Indian/Native American | 5 | 7% |
| Other | 3 | 4% |
| Housing status at enrollment | ||
| Single room occupancy | 5 | 7% |
| Transitional housing | 9 | 12% |
| Treatment program | 2 | 3% |
| Couch surfing | 11 | 15% |
| Shelter | 10 | 13% |
| Street | 38 | 51% |
| Baseline CD4 count (cells/mm3) | ||
| <200 | 30 | 40% |
| 200–349 | 20 | 27% |
| 350–499 | 16 | 21% |
| ≥500 | 12 | 16% |
| Substance use disorder (any) | 75 | 100% |
| Methamphetamine | 68 | 91% |
| Cocaine | 8 | 11% |
| Opioids | 11 | 15% |
| Alcohol | 7 | 9% |
| Mental health disorder (any) | 58 | 77% |
| Psychotic disorder | 12 | 16% |
| Bipolar disorder | 11 | 15% |
| Depressive disorder | 38 | 51% |
| Anxiety disorder | 14 | 19% |